Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof
US-12247058-B2 · Mar 11, 2025 · US
This page is not indexed by search engines while we improve data quality.
Morin Paul E patents
Morin Paul E is listed as an inventor on 47 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Morin Paul E |
| Total patents | 47 |
| First publication | Mar 3, 2015 |
| Latest publication | Mar 11, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
PD-L1 binding polypeptides for imaging
US-12194110-B2 · Jan 14, 2025 · US
Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides
US-12097241-B2 · Sep 24, 2024 · US
Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides
US-12097242-B2 · Sep 24, 2024 · US
Radiolabeled fibronectin based scaffolds and antibodies and theranostic uses thereof
US-2024277878-A1 · Aug 22, 2024 · US
Prodruggable antibodies, prodrugs thereof, and methods of use and making
US-2023295346-A1 · Sep 21, 2023 · US
Methods and compositions for deuterated biologics
US-11623013-B2 · Apr 11, 2023 · US
Prodruggable antibodies, prodrugs thereof, and methods of use and making
US-11623965-B2 · Apr 11, 2023 · US
Il-10 and uses thereof
US-2023087600-A1 · Mar 23, 2023 · US
Pet imaging with pd-l1 binding polypeptides
US-2022347324-A1 · Nov 3, 2022 · US
Recent patents
Latest publications not already listed above.
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
US-2022331402-A1 · Oct 20, 2022 · US
Anti-ctla4 antibody prodruggable (probody) at a cdr position
US-2022251206-A1 · Aug 11, 2022 · US
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
US-2022211812-A1 · Jul 7, 2022 · US
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof
US-11364281-B2 · Jun 21, 2022 · US
Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides
US-2022185856-A1 · Jun 16, 2022 · US
PET imaging with PD-L1 binding polypeptides
US-11344639-B2 · May 31, 2022 · US
Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides
US-11248031-B2 · Feb 15, 2022 · US
Novel pd-l1 binding polypeptides for imaging
US-2022001040-A1 · Jan 6, 2022 · US
Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides
US-11185570-B2 · Nov 30, 2021 · US
PD-L1 binding polypeptides for imaging
US-11173219-B2 · Nov 16, 2021 · US
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
US-2021196791-A1 · Jul 1, 2021 · US
Methods and compositions for deuterated biologics
US-2021060184-A1 · Mar 4, 2021 · US
Serum albumin binding molecules
US-10934572-B2 · Mar 2, 2021 · US
Modified FGF-21 Polypeptides and Uses Thereof
US-2019382460-A1 · Dec 19, 2019 · US
Novel pd-l1 binding polypeptides for imaging
US-2019343972-A1 · Nov 14, 2019 · US
PD-L1 binding polypeptides for imaging
US-10406251-B2 · Sep 10, 2019 · US
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
US-2019256570-A1 · Aug 22, 2019 · US
Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof
US-10377806-B2 · Aug 13, 2019 · US
Serum albumin binding molecules
US-2019203248-A1 · Jul 4, 2019 · US
Pet imaging with pd-l1 binding polypeptides
US-2019184042-A1 · Jun 20, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bristol Myers Squibb Co | 47 |
| Gosselin Michael L | 1 |
| Fabrizio David | 1 |
| Swain Joanna F | 1 |
| Mitchell Tracy | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.